Download PDF
Endoscopy 2019; 51(06): 532-539
DOI: 10.1055/a-0852-3441
Original article
© Georg Thieme Verlag KG Stuttgart · New York

Endoscopic sleeve gastroplasty versus intragastric balloon insertion: efficacy, durability, and safety

Lea Fayad
1   Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
,
Lawrence J. Cheskin
2   Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
,
Atif Adam
2   Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
,
Dilhana S. Badurdeen
1   Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
,
Christine Hill
2   Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
,
Abhishek Agnihotri
1   Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
,
Margo Dunlap
1   Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
,
Cem Simsek
1   Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
,
Mouen A. Khashab
1   Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
,
Anthony N. Kalloo
1   Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
,
Vivek Kumbhari
1   Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
› Author Affiliations
Further Information

Publication History

submitted 27 May 2018

accepted after revision 14 January 2019

Publication Date:
06 March 2019 (online)

Also available at
   Permissions and Reprints

Abstract

Background Intragastric balloon (IGB) placement and endoscopic sleeve gastroplasty (ESG) are reported to be safe and effective endoscopic bariatric therapies. This study aimed to compare the patient demographics and therapeutic outcomes between the IGB and ESG procedures.

Methods: This was a retrospective review of prospectively collected data from consecutive patients between December 2015 and October 2017 who underwent IGB or ESG at a single academic center. Fluid-filled IGBs implanted for a 6-month duration were used. IGB and ESG patients were subjected to identical post-procedure dietary instructions and follow-up protocols. Body weight was recorded at 1, 3, 6, and 12 months post-procedure.

Results A total of 47 patients underwent IGB insertion and 58 underwent ESG. The IGB cohort had a lower baseline body mass index (BMI) than the ESG (34.5 vs. 41.5 kg/m2; P < 0.001) and a significantly lower proportion of men (2.1 % vs. 41.4 %; P < 0.001). IGB patients showed a mean (standard deviation [SD]) percentage total body weight loss (%TBWL) that was significantly lower than ESG patients at 1 month (6.6 % [2.6 %] vs. 9.9 % [2.4 %]; P < 0.001), 3 months (11.1 % [4.4 %] vs. 14.3 % [4.6 %]; P = 0.004), 6 months (15.0 % [7.6 %] vs. 19.5 % [5.7 %]; P = 0.01), and 12 months (13.9 % [9.0 %] vs. 21.3 % [6.6 %]; P = 0.005). The IGB cohort also experienced significantly more adverse events compared with the ESG (17 % vs. 5.2 %; P = 0.048).

Conclusions IGB placement and ESG result in clinically meaningful weight loss. However, ESG appears to provide clinically superior and more enduring weight loss with fewer adverse events compared with an IGB.

Refers to:

To balloon or to suture, that is the questionEndoscopy 2019; 51(06): 513-514
DOI: 10.1055/a-0894-4479

 

  • References

  • 1 Ng M, Fleming T, Robinson M. et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014; 384: 766-781
    CrossrefPubMedGoogle Scholar
  • 2 Hill C, Khashab MA, Kalloo AN. et al. Endoluminal weight loss and metabolic therapies: current and future techniques. Ann N Y Acad Sci 2018; 1411: 36-52
    CrossrefPubMedGoogle Scholar
  • 3 Yorke E, Switzer NJ, Reso A. et al. Intragastric balloon for management of severe obesity: a systematic review. Obes Surg 2016; 26: 2248-2254
    CrossrefPubMedGoogle Scholar
  • 4 Tate CM, Geliebter A. Intragastric Balloon treatment for obesity: review of recent studies. Adv Ther 2017; 34: 1859-1875
    CrossrefPubMedGoogle Scholar
  • 5 Ponce J, Woodman G, Swain J. et al. The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity. Surg Obes Relat Dis 2015; 11: 874-881
    CrossrefPubMedGoogle Scholar
  • 6 Abu Dayyeh BK, Kumar N, Edmundowicz SA. et al. ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc 2015; 82: 425-438.e425
    CrossrefPubMedGoogle Scholar
  • 7 Kotzampassi K, Grosomanidis V, Papakostas P. et al. 500 intragastric balloons: what happens 5 years thereafter?. Obes Surg 2012; 22: 896-903
    CrossrefPubMedGoogle Scholar
  • 8 Genco A, Lopez-Nava G, Wahlen C. et al. Multi-centre European experience with intragastric balloon in overweight populations: 13 years of experience. Obes Surg 2013; 23: 515-521
    CrossrefPubMedGoogle Scholar
  • 9 Ponce J, Quebbemann BB, Patterson EJ. Prospective, randomized, multicenter study evaluating safety and efficacy of intragastric dual-balloon in obesity. Surg Obes Relat Dis 2013; 9: 290-295
    CrossrefPubMedGoogle Scholar
  • 10 Courcoulas A, Abu Dayyeh BK, Eaton L. et al. Intragastric balloon as an adjunct to lifestyle intervention: a randomized controlled trial. Int J Obes 2017; 41: 427-433
    CrossrefPubMedGoogle Scholar
  • 11 Steele CB, Thomas CC, Henley SJ. et al. Vital signs: trends in incidence of cancers associated with overweight and obesity - United States, 2005-2014. MMWR Morb Mortal Wkly Rep 2017; 66: 1052-1058
    CrossrefPubMedGoogle Scholar
  • 12 Vargas EJ, Pesta CM, Bali A. et al. Single fluid-filled intragastric balloon safe and effective for inducing weight loss in a real-world population. Clin Gastroenterol Hepatol 2018; DOI: 10.1016/j.cgh.2018.01.046.
    CrossrefPubMedGoogle Scholar
  • 13 Lopez-Nava G, Galvao MP, Bautista-Castano I. et al. Endoscopic sleeve gastroplasty: how I do it?. Obes Surg 2015; 25: 1534-1538
    CrossrefPubMedGoogle Scholar
  • 14 Barola S, Chen YI, Ngamruengphong S. et al. Technical aspects of endoscopic sleeve gastroplasty. Gastrointest Endosc 2017; 85: 862
    CrossrefPubMedGoogle Scholar
  • 15 Lopez-Nava G, Sharaiha RZ, Vargas EJ. et al. Endoscopic sleeve gastroplasty for obesity: a multicenter study of 248 patients with 24 months follow-up. Obes Surg 2017; 27: 2649-2655
    CrossrefPubMedGoogle Scholar
  • 16 Sartoretto A, Sui Z, Hill C. et al. Endoscopic sleeve gastroplasty (ESG) is a reproducible and effective endoscopic bariatric therapy suitable for widespread clinical adoption: a large, international multicenter study. Obes Surg 2018; DOI: 10.1007/s11695-018-3135-x.
    CrossrefPubMedGoogle Scholar
  • 17 Barola S, Agnihotri A, Khashab MA. et al. Perigastric fluid collection after endoscopic sleeve gastroplasty. Endoscopy 2016; 48: E340-E341
    Article in Thieme ConnectPubMedGoogle Scholar
  • 18 Agnihotri A, Xie A, Bartalos C. et al. Real-world safety and efficacy of fluid-filled dual intra-gastric balloon for weight loss. Clin Gastroenterol Hepatol 2018; DOI: 10.1016/j.cgh.2018.02.026.
    CrossrefPubMedGoogle Scholar
  • 19 Kumar N, Abu Dayyeh BK, Lopez-Nava Breviere G. et al. Endoscopic sutured gastroplasty: procedure evolution from first-in-man cases through current technique. Surg Endosc 2018; 32: 2159-2164
    CrossrefPubMedGoogle Scholar
  • 20 Graus Morales J, Crespo Perez L, Marques A. et al. Modified endoscopic gastroplasty for the treatment of obesity. Surg Endosc 2018; 32: 3936-3942
    CrossrefPubMedGoogle Scholar
  • 21 Novikov AA, Afaneh C, Saumoy M. et al. Endoscopic sleeve gastroplasty, laparoscopic sleeve gastrectomy, and laparoscopic band for weight loss: how do they compare?. J Gastrointest Surg 2018; 22: 267-273
    CrossrefPubMedGoogle Scholar
  • 22 Lopez-Nava G, Galvao M, Bautista-Castano I. et al. Endoscopic sleeve gastroplasty with 1-year follow-up: factors predictive of success. Endosc Int Open 2016; 4: E222-E227
    Article in Thieme ConnectPubMedGoogle Scholar
  • 23 Sharaiha RZ, Kumta NA, Saumoy M. et al. Endoscopic sleeve gastroplasty significantly reduces body mass index and metabolic complications in obese patients. Clin Gastroenterol Hepatol 2017; 15: 504-510
    CrossrefPubMedGoogle Scholar
  • 24 Sacks FM, Bray GA, Carey VJ. et al. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. NEJM 2009; 360: 859-873
    CrossrefPubMedGoogle Scholar
  • 25 Fuchs HF, Broderick RC, Harnsberger CR. et al. Benefits of bariatric surgery do not reach obese men. J Laparoendosc Adv Surg Tech A 2015; 25: 196-201
    CrossrefPubMedGoogle Scholar
  • 26 Hill C, El Zein M, Agnihotri A. et al. Endoscopic sleeve gastroplasty: the learning curve. Endosc Int Open 2017; 5: E900-E904
    Article in Thieme ConnectPubMedGoogle Scholar
  • 27 Popov VB, Ou A, Schulman AR. et al. The impact of intragastric balloons on obesity-related co-morbidities: a systematic review and meta-analysis. Am J Gastroenterol 2017; 112: 429-439
    CrossrefPubMedGoogle Scholar